Bioline Diagnostics LLP Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Bioline Diagnostics LLP Pharmaceutical Export Portfolio Dataset — 2 Products, $276.3K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Bioline Diagnostics LLP — Pharmaceutical Exporter Profile (2026) | 2 Products, $276.3K Trade | TransData Nexus

Bioline Diagnostics LLP

Indian Pharmaceutical Exporter · Medical Devices & Diagnostics Specialist · $276.3K Total Trade · DGFT Verified

Bioline Diagnostics LLP is an Indian pharmaceutical exporter with a total trade value of $276.3K across 2 products in 1 therapeutic categories. Based on 146 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Reagent ($138.3K), Diagnostic ($138.0K), .

Bioline Diagnostics LLP — Export Portfolio & Destination Treemap

Bioline Diagnostics LLP pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Bioline Diagnostics LLP? — Company Overview & Market Position

Bioline Diagnostics LLP, established on April 10, 2017, is a healthcare-focused limited liability partnership based in Delhi, India. The company specializes in the development, manufacturing, and marketing of high-quality diagnostic products, including immunochromatographic tests, biochemistry test reagents, point-of-care testing (POCT) solutions, and diagnostic instruments such as hematology and biochemistry analyzers.

The firm's registered office is located at H.No. 1478, Block-H, DSIDC, Narela, Delhi, 110040, India. As of April 5, 2024, Bioline Diagnostics LLP employed 62 professionals. The company's authorized capital is ₹500,000, with a paid-up capital of ₹500,000.

What Does Bioline Diagnostics LLP Export? — Product Portfolio Analysis

Top Products by Export Value

1Reagent$138.3K 2Diagnostic$138.0K

Bioline Diagnostics LLP Therapeutic Categories — 1 Specializations

Product Portfolio — Top 2 by Export Value

Bioline Diagnostics LLP exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Reagent	Medical Devices & Diagnostics	$138.3K	75	1.1%	7
2	Diagnostic	Medical Devices & Diagnostics	$138.0K	71	0.7%	14

Bioline Diagnostics LLP exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $276.3K. The top category is Medical Devices & Diagnostics (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Bioline Diagnostics LLP — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Bioline Diagnostics LLP operates a state-of-the-art manufacturing facility in New Delhi, certified with ISO 13485, ISO 9001, and Good Manufacturing Practice (GMP) standards. The facility spans 1,000 square meters and includes production, quality control, and quality assurance departments. It is equipped with temperature and humidity control systems, a well-established R&D laboratory, stability chambers, and dedicated areas for raw materials and packaging.

3Key Leadership

The leadership team at Bioline Diagnostics LLP comprises:

Shraey Sanjay Gupta: Designated Partner
Ansh Sanjay Gupta: Designated Partner
Nimit Goyal: Designated Partner
Ramesh Chakraborty: Designated Partner
Sanjay Pawan Gupta: Designated Partner

These individuals collectively oversee the strategic direction and operations of the company.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Bioline Diagnostics LLP Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Bioline Diagnostics LLP's export activities, as per TransData Nexus proprietary trade data, include:

Total Export Value: $276,000 USD
Total Shipments: 146
Products Exported: 2 across 1 therapeutic category
Top 5 Products: Reagent ($138,000, Rank #7, 1.1% market share); Diagnostic ($138,000, Rank #14, 0.7% market share)
Top 3 Categories: Medical Devices & Diagnostics (100.0%)
Portfolio Concentration: Top 5 products = 100%

The company's focus on finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, underscores its commitment to delivering comprehensive diagnostic solutions.

2Emerging Markets

Bioline Diagnostics LLP — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Bioline Diagnostics LLP's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. The company's focus on diagnostic products may influence its regulatory interactions with the FDA.

2WHO & EU GMP

While Bioline Diagnostics LLP's manufacturing facility is certified with ISO 13485, ISO 9001, and GMP standards, specific information regarding WHO prequalification and EU GMP certificates is not publicly disclosed. The company's adherence to these international standards suggests a commitment to quality that may facilitate access to global markets.

3CDSCO & Indian Regulatory

Bioline Diagnostics LLP operates under the regulatory framework of the Central Drugs Standard Control Organisation (CDSCO) in India. The company's compliance with GMP standards indicates adherence to CDSCO's manufacturing guidelines. Specific details regarding state drug controller approvals and export No Objection Certificates (NOCs) are not publicly available.

Bioline Diagnostics LLP — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Bioline Diagnostics LLP operates in the competitive diagnostics sector, focusing on immunochromatographic tests, biochemistry test reagents, POCT solutions, and diagnostic instruments. While specific competitors are not identified, the company's commitment to quality and affordability positions it favorably in the market.

2Key Differentiators

Bioline Diagnostics LLP's key differentiators include its focus on finished pharmaceutical formulations, adherence to international quality standards, and a concentrated product portfolio. These factors contribute to the company's competitive edge in the diagnostics market.

3Strategic Position

Bioline Diagnostics LLP's strategic direction emphasizes the development and marketing of high-quality diagnostic products at affordable prices. The company's focus on finished pharmaceutical formulations and adherence to international standards positions it well for future growth in both domestic and international markets.

Buyer Due Diligence Brief — Evaluating Bioline Diagnostics LLP as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Bioline Diagnostics LLP's track record in the diagnostics sector is characterized by a focused product portfolio and adherence to international quality standards. The company's export volume and consistency are not detailed in publicly available sources, but its strategic focus suggests a reliable supply chain.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Registration: Confirm the facility's registration status with the FDA.
WHO Prequalification: Verify the product's prequalification status with the World Health Organization.
EU GMP Certification: Ensure the manufacturing facility holds a valid EU GMP certificate.
ISO Certifications: Check for ISO 13485 and ISO 9001 certifications.

Frequently Asked Questions — Bioline Diagnostics LLP

How many pharmaceutical products does Bioline Diagnostics LLP export from India?

Bioline Diagnostics LLP exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Reagent ($138.3K), Diagnostic ($138.0K). Total export value is $276.3K.

What is Bioline Diagnostics LLP's total pharmaceutical export value?

Bioline Diagnostics LLP's total pharmaceutical export value is $276.3K, based on 146 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Bioline Diagnostics LLP cover?

Bioline Diagnostics LLP exports across 1 therapeutic categories. The largest are Medical Devices & Diagnostics (100.0%, 2 products).

Get Full Bioline Diagnostics LLP Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.